Pfizer ($PFE), which faces thousands of lawsuits over hormone replacement therapies, will cut about 40% of the workforce at a Canadian plant where one of them is made.

Getting clinical trials right, and right the first time, is crucial for biopharma companies, especially as the cost of getting a drug to market is skyrocketing. Matthew Herper estimates in "The...

> Indian API-maker Orchid Chemicals & Pharmaceuticals reported dismal results in its last quarter, in part because a plant in India was closed after pollution concerns. Story > Johnson...

Vetter, the German contract manufacturer that specializes in aseptic filling, has invested $45 million in a new temperature controlled warehouse.

Because of EU trade rules and a weak pound, wholesalers are sourcing drugs in the U.K. then selling their supplies to countries where they can make more money, Reuters reports.

Hospira has had to recall another lot of medication, this time syringes believed to contain too much of a pain killer.

The U.K. regulators who should have been there to protect the health of patients, fell down on the job when it came to the silicone breast implants made with substandard materials, received by thousands of women, according to a government review published Monday.

May 15, 2012 Merck Announces Details of Merck Serono Efficiency Program and Introduces Merck Group Mid-Term Financial Targets • Merck Serono net savings target: € 300 million by 2014...

Merck KGaA today put euro signs to the restructuring it announced last month, which includes some cuts to its manufacturing division.

An investigation into whether two drug manufacturing companies in Pakistan turned ephedrine allocations into street drugs may be taking on an international aspect.